Takashi Kakinuma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takashi Kakinuma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Koichiro Nakamura
3 shared publicationsKunihiko Tamaki
2 shared publicationsMotoshi Wakugawa
2 shared publicationsAkihiko Asahina
1 shared publication- Akiko Nishibu
Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan
1 shared publication Fumio Kaneko
1 shared publication
Latest Publications
- 2 September 2003
- Vol. 13 (4) , 348-53
Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line.
Ultraviolet A (UVA) irradiation modulates the immunological functions of skin. We examined the effect of UVA irradiation on the basal and the IFN-gamma-and TNF-alpha-stimulation-induced production of thymus-and activation-regulated chemokine (TARC/CCL17) using HaCaT cells. UVA irradiation inhibited the basal levels of both TARC mRNA expression and TARC protein production. UVA irradiation also significantly inhibited TARC mRNA expression and TARC protein secretion that were induced by co-stimulation with IFN-y and TNF-alpha. A time course study showed that: the significant suppression of TARC mRNA expression was detected 8 hours after irradiation and continued for 36 hours; the strongest inhibition of TARC protein secretion occurred in the first 8 hours after UVA irradiation and continued for 36 hours. Our data provide the first evidence that UVA inhibits TARC mRNA expression and TARC protein production by keratinocytes in a dose-dependent manner. These results may suggest an explanation for the UV-induced therapeutic effect.
- 2 September 2003
- Vol. 13 (4) , 348-53
Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line.
Ultraviolet A (UVA) irradiation modulates the immunological functions of skin. We examined the effect of UVA irradiation on the basal and the IFN-gamma-and TNF-alpha-stimulation-induced production of thymus-and activation-regulated chemokine (TARC/CCL17) using HaCaT cells. UVA irradiation inhibited the basal levels of both TARC mRNA expression and TARC protein production. UVA irradiation also significantly inhibited TARC mRNA expression and TARC protein secretion that were induced by co-stimulation with IFN-y and TNF-alpha. A time course study showed that: the significant suppression of TARC mRNA expression was detected 8 hours after irradiation and continued for 36 hours; the strongest inhibition of TARC protein secretion occurred in the first 8 hours after UVA irradiation and continued for 36 hours. Our data provide the first evidence that UVA inhibits TARC mRNA expression and TARC protein production by keratinocytes in a dose-dependent manner. These results may suggest an explanation for the UV-induced therapeutic effect.
- 1 February 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 148 (2) , 203-210
High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid
Summary Background Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by eosinophilia and high serum IgE levels. The accumulated evidence suggests that various cytokines are i...
- 1 February 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 148 (2) , 203-210
High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid
Summary Background Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by eosinophilia and high serum IgE levels. The accumulated evidence suggests that various cytokines are i...
- 1 January 2003
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 48 (1) , 23-30
Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides
- 1 January 2003
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 48 (1) , 23-30
Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides